Cargando…
The activation of SIRT3 by dexmedetomidine mitigates limb ischemia-reperfusion–induced lung injury
BACKGROUND: The lung is one of the most sensitive organs, and is vulnerable to injury caused by limb ischemia-reperfusion (LIR). Dexmedetomidine, an anesthetic adjunct, has been shown to have therapeutic effects on lung injury secondary to LIR. This study aimed to investigate the role of dexmedetomi...
Autores principales: | Wang, Lei, Ding, Yanling, Bai, Yanhui, Shi, Jian, Li, Jia, Wang, Xiuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9011293/ https://www.ncbi.nlm.nih.gov/pubmed/35434046 http://dx.doi.org/10.21037/atm-22-711 |
Ejemplares similares
-
Protective Effects of Dexmedetomidine and Oxycodone in Patients Undergoing Limb Ischemia-Reperfusion
por: Cheng, Wenjie, et al.
Publicado: (2019) -
Effect of dexmedetomidine on lung ischemia-reperfusion injury
por: JIANG, LILI, et al.
Publicado: (2014) -
The Application and Analytical Pathway of Dexmedetomidine in Ischemia/Reperfusion Injury
por: Tang, Ying, et al.
Publicado: (2019) -
Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020) -
Effect of dexmedetomidine pretreatment on lung injury following intestinal ischemia-reperfusion
por: SHEN, JINMEI, et al.
Publicado: (2013)